PBSerum HA 2.0 HIGH is a range of products developed by the Spanish laboratory Proteos Biotech, utilizing cutting-edge technology involving recombinant enzymes. It incorporates high molecular weight hyaluronic acid blended with a reactant featuring a meticulously balanced enzyme mix. These formulations are proficient in addressing concerns such as scars, stretch marks, cellulite, and the reduction of fat deposits.
The package includes:
- 1. PBSerum HA 2.0:
PBserum HA2.0 is a hyaluronic acid with a high molecular weight of 8 mg/ml and slightly cross-linked. It has anti-inflammatory, regenerative properties and stimulates the reorganization of collagen fibers in damaged tissues. Thanks to its characteristics, it is suitable for inhibiting, combating and preventing the appearance of fibrosis, which is the basis of our treatment. PBSerum HA2.0 is compatible with the use of enzymatic reagents of different intensity.
- 2. Moderate enzyme reagent “MEDIUM”:
It helps to reduce excess body fat accompanying fibrosis. It stimulates lipid metabolism and triglyceride degradation to reduce the volume of adipocytes in areas with excessive accumulated fat. Contains active substances: Col G / H collagenase PB220, Lipase PB500, LYA Lyase PB72K
Ingredients of the product:
- Hyaluronic acid with a high molecular weight of 8 mg/ml and slightly cross-linked
- Col G / H collagenase PB220
- Lipase PB500
- LYA Lyase PB72K
The advantages of utilizing of PBSerum HA 2.0 HIGH:
- The biotechnological process employing microorganisms enables the production of pure enzymes with a simplified structure, ensuring the products are effective and hypoallergenic.
- Freeze drying, a preservation method involving rapid freezing, maintains the stability of the products. Enzymes retain their properties and remain active without the addition of preservatives. Production occurs within a class A cleanroom, ensuring product sterility. Freeze-drying negates the need for low-temperature storage, with a range of 1-30°C.
- In vitro and in vivo testing of PBSerum MEDICAL enzymes demonstrates their efficacy in fibrosis treatment, with visible effects observed after the initial application. The sterile preservation of recombinant enzymes through freeze-drying ensures the products possess a high level of safety.
Product Application Guidelines:
Recommended sessions: 1-4.
Initial visible results appear approximately 3 weeks after injection.
Retreatment interval: 14 days.